PHASE-III STUDY OF BCOP V CHOP IN UNFAVORABLE CATEGORIES OF MALIGNANT-LYMPHOMA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL

被引:39
作者
GAMS, RA
RAINEY, M
DANDY, M
BARTOLUCCI, AA
SILBERMAN, H
OMURA, G
机构
关键词
D O I
10.1200/JCO.1985.3.9.1188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1188 / 1195
页数:8
相关论文
共 19 条
[1]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]  
COX DR, 1970, ANAL BINARY DATA, pCH2
[4]  
DURANT JR, 1977, CANCER TREAT REP, V61, P1085
[5]   1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA(BCNU), CYCLOPHOSPHAMIDE, VINCRISTINE-(BCOP) AND PREDNISONE-(BCOP) - NEW THERAPEUTIC REGIMEN FOR DIFFUSE HISTIOCYTIC LYMPHOMA [J].
DURANT, JR ;
LOEB, V ;
DORFMAN, R ;
CHAN, YK .
CANCER, 1975, 36 (06) :1936-1944
[6]   DIFFUSE AGGRESSIVE LYMPHOMAS - INCREASED SURVIVAL AFTER ALTERNATING FLEXIBLE SEQUENCES OF PROMACE AND MOPP CHEMOTHERAPY [J].
FISHER, RI ;
DEVITA, VT ;
HUBBARD, SM ;
LONGO, DL ;
WESLEY, R ;
CHABNER, BA ;
YOUNG, RC .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (03) :304-309
[7]  
GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[8]   COMBINATION CHEMOTHERAPY IN LYMPHOSARCOMA AND RETICULUM CELL SARCOMA [J].
HOOGSTRATEN, B ;
OWENS, AH ;
LENHARD, RE ;
GLIDEWELL, OJ ;
LEONE, LA ;
OLSON, KB ;
HARLEY, JB ;
TOWNSEND, SR ;
MILLER, SP ;
SPURR, CL .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1969, 33 (2P2) :370-+
[9]  
JONES SE, 1979, CANCER, V43, P417, DOI 10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO
[10]  
2-I